suspension for injection
Sponsors
Stichting Radboud University Medical Center, Allergy Therapeutics (UK) Limited, Mater Misericordiae University Hospital, Inmunotek S.L.
Conditions
Grass pollen induced moderate-to-severe allergic rhinitis or rhinoconjunctivitis with or without mild-to-moderate asthmaPertussis or 'whooping cough'Post-surgical scar painSeasonal allergic rhinitis/rhinoconjunctivitis induced by grass pollen exposure
Phase 3
A long-term, double-blind, randomised, placebo-controlled clinical trial to investigate the efficacy and safety of PQ Grass 27600 SU in children and adolescents with seasonal allergic rhinitis/rhinoconjunctivitis induced by grass pollen exposure
RecruitingCTIS2023-508520-36-00
Start: 2024-09-06Target: 358Updated: 2025-12-09
A prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial to evaluate the efficacy and safety of subcutaneous immunotherapy with polymerized grass pollen extracts in patients with grass pollen–induced allergic rhinitis/rhinoconjunctivitis with or without mild-to-moderate asthma
Not yet recruitingCTIS2026-526100-73-00
Target: 171Updated: 2026-10-01
Phase 4
A phase 4, randomised vaccination study in healthy adults to investigate the effects of acellular pertussis vaccine on colonisation with Bordetella pertussis using controlled human infection (KIM-study)
RecruitingCTIS2023-508416-35-00
Start: 2024-10-16Target: 99Updated: 2026-01-26
Efficacy of botulinum toxin vs corticosteroid in the management of persistent post-surgical scar pain
Not yet recruitingCTIS2024-518954-18-01
Target: 60Updated: 2024-12-05